Publications (743) RAFAEL MARÍA CANTÓN MORENO publications

filter_list

2026

  1. Cefiderocol activity against multidrug-resistant isolates from the PERSEUS study: relationship between cefiderocol minimum inhibitory concentration and clinical outcomes

    Journal of Antimicrobial Chemotherapy, Vol. 81, Núm. 6

  2. Diagnostic and antimicrobial stewardship programs for the management of infectious diseases in the era of artificial intelligence

    Enfermedades Infecciosas y Microbiologia Clinica

  3. Epidemiology and antimicrobial resistance patterns of Aeromonas species in Europe, 2020-2024 (AEuROMONAS)

    Diagnostic Microbiology and Infectious Disease, Vol. 115, Núm. 4

  4. How to: the application and analysis of categorical agreement in antimicrobial susceptibility testing using European Committee on Antimicrobial Susceptibility Testing breakpoints

    Clinical Microbiology and Infection, Vol. 32, Núm. 6, pp. 916-920

  5. Identification and functional insights into new phage tail-like bacteriocins targeting Pseudomonas aeruginosa as new antimicrobials

    Microbiology Spectrum

  6. In Vitro Restoration of Colistin Susceptibility by Ivacaftor Synergy with Limited Reproducibility in a Murine Pneumonia Model

    Antibiotics, Vol. 15, Núm. 4

  7. Minor non-fermenting Gram-negative bacilli in Europe, 2020–2024 (MINOFEu)

    International Journal of Antimicrobial Agents, Vol. 67, Núm. 6

  8. Nanomotion-enabled ultra-rapid antibiotic susceptibility testing with magnetic bead-based pathogen enrichment for accelerated sepsis diagnostics

    Scientific Reports, Vol. 16, Núm. 1

  9. Phages and quorum sensing: findings to consider in phage therapy

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 45, Núm. 3, pp. 615-629

  10. Plasma calprotectin as a severity biomarker in pediatric invasive Streptococcus pyogenes infections: insights from a multicenter immune profiling study during an outbreak

    Journal of Microbiology, Immunology and Infection, Vol. 59, Núm. 1, pp. 62-70

  11. Qualitative analysis of genomic mutations and antibiotic susceptibility testing of Pseudomonas aeruginosa isolates from chronic lung infections

    PLOS ONE, Vol. 21, Núm. 3 March

  12. Rectal Colonization by Carbapenemase-Producing Enterobacterales in a Tertiary Care Hospital in Havana, Cuba

    Antibiotics, Vol. 15, Núm. 1

2025

  1. A European survey on anaerobes from paediatric blood cultures: a comparative analysis with adults

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 44, Núm. 9, pp. 2207-2217

  2. Activity of imipenem-relebactam, ceftolozane-tazobactam and comparators against clinical isolates of Enterobacterales and Pseudomonas aeruginosa causing severe infections in hematological and oncological patients: A prospective multicenter study

    International Journal of Antimicrobial Agents, Vol. 66, Núm. 3

  3. Aminoglycoside breakpoints—the EUCAST approach and what this means for the clinician

    Clinical Microbiology and Infection

  4. Antechodynamics and Antechokinetics: Dynamics and Kinetics of Antibiotic Resistance Biomolecules

    Biomolecules, Vol. 15, Núm. 6

  5. Burden of bacterial antimicrobial resistance among hospitalised patients in Spain: findings from three nationwide prospective studies

    The Lancet Regional Health - Europe, Vol. 51

  6. CRISPR-associated Plasmonic Colorimeter Method (Ca-PCM): A real-time RGB detection system for gold nanoparticles-based nucleic acid biosensors

    Analytica Chimica Acta, Vol. 1338

  7. Cefepime-enmetazobactam: first approved cefepime-β- lactamase inhibitor combination for multi-drug resistant Enterobacterales

    Future Microbiology, Vol. 20, Núm. 4, pp. 277-286

  8. Cefiderocol AST in a real-life Klebsiella pneumoniae collection: challenges in the ATU range

    Journal of Antimicrobial Chemotherapy, Vol. 80, Núm. 3, pp. 797-801